{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T05:00:10Z","timestamp":1783400410159,"version":"3.54.6"},"reference-count":111,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,1,27]],"date-time":"2022-01-27T00:00:00Z","timestamp":1643241600000},"content-version":"vor","delay-in-days":210,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000923","name":"Australian Research Council","doi-asserted-by":"publisher","award":["APP1102532"],"award-info":[{"award-number":["APP1102532"]}],"id":[{"id":"10.13039\/501100000923","id-type":"DOI","asserted-by":"publisher"}]},{"name":"NICM Health Research Institute"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Advances in Nutrition"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1093\/advances\/nmaa180","type":"journal-article","created":{"date-parts":[[2020,12,22]],"date-time":"2020-12-22T07:13:03Z","timestamp":1608621183000},"page":"1571-1593","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"title":["The Efficacy of Ketogenic Therapies in the Clinical Management of People with Neurodegenerative Disease: A Systematic Review"],"prefix":"10.1016","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0063-5228","authenticated-orcid":false,"given":"Lauren S","family":"Dewsbury","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3526-8405","authenticated-orcid":false,"given":"Chai K","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8708-6104","authenticated-orcid":false,"given":"Genevieve Z","family":"Steiner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1093\/advances\/nmaa180_bib1","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.1002\/jnr.24064","article-title":"The vicious circle of hypometabolism in neurodegenerative diseases: ways and mechanisms of metabolic correction","volume":"95","author":"Zilberter","year":"2017","journal-title":"J Neurosci Res"},{"key":"10.1093\/advances\/nmaa180_bib2","first-page":"3","article-title":"New hopes and challenges for treatment of neurodegenerative disorders: great opportunities for young neuroscientists","volume":"4","author":"Kiaei","year":"2013","journal-title":"Basic Clin Neurosci"},{"key":"10.1093\/advances\/nmaa180_bib3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fnins.2015.00469","article-title":"Chronic glutamate toxicity in neurodegenerative diseases \u2013 what is the evidence?","volume":"9","author":"Lewerenz","year":"2015","journal-title":"Front Neurosci"},{"key":"10.1093\/advances\/nmaa180_bib4","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1172\/JCI105481","article-title":"Hormone-fuel interrelationships during fasting","volume":"45","author":"Cahill","year":"1966","journal-title":"J Clin Invest"},{"key":"10.1093\/advances\/nmaa180_bib5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fnagi.2018.00301","article-title":"The emerging role of energy metabolism and neuroprotective strategies in Parkinson\u2019s disease","volume":"10","author":"B\u0142aszczyk","year":"2018","journal-title":"Front Aging Neurosci"},{"key":"10.1093\/advances\/nmaa180_bib6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/sj.jcbfm.9600543","article-title":"Cerebral metabolic adaptation and ketone metabolism after brain injury","volume":"28","author":"Prins","year":"2008","journal-title":"J Cereb Blood Flow Metab"},{"key":"10.1093\/advances\/nmaa180_bib7","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.cmet.2016.12.022","article-title":"Multi-dimensional roles of ketone bodies in fuel metabolism, signaling, and therapeutics access","volume":"25","author":"Puchalska","year":"2017","journal-title":"Cell Metab"},{"key":"10.1093\/advances\/nmaa180_bib8","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.plefa.2003.09.007","article-title":"The therapeutic implications of ketone bodies: the effects of ketone bodies in pathological conditions: ketosis, ketogenic diet, redox states, insulin resistance, and mitochondrial metabolism","volume":"70","author":"Veech","year":"2004","journal-title":"Prostaglandins, Leukotrienes Essent Fatty Acids"},{"key":"10.1093\/advances\/nmaa180_bib9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1146\/annurev.nutr.26.061505.111258","article-title":"Fuel metabolism in starvation","volume":"26","author":"Cahill","year":"2006","journal-title":"Annu Rev Nutr"},{"key":"10.1093\/advances\/nmaa180_bib10","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/474296","article-title":"Ketogenic diet in neuromuscular and neurodegenerative diseases","volume":"2014","author":"Paoli","year":"2014","journal-title":"Biomed Res Int"},{"key":"10.1093\/advances\/nmaa180_bib11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.21767\/2171-6625.1000188","article-title":"Systematic review of the use of ketones in the management of acute and chronic neurological disorders","volume":"08","author":"White","year":"2017","journal-title":"J Neurol Neurosci"},{"key":"10.1093\/advances\/nmaa180_bib12","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1097\/00008877-200609000-00009","article-title":"Neuroprotective and disease-modifying effects of the ketogenic diet","volume":"17","author":"Gasior","year":"2006","journal-title":"Behav Pharmacol"},{"issue":"4","key":"10.1093\/advances\/nmaa180_bib13","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.neuron.2012.03.032","article-title":"BAD-dependent regulation of fuel metabolism and K(ATP) channel activity confers resistance to epileptic seizures","volume":"74","author":"Gim\u00e9nez-Cassina","year":"2012","journal-title":"Neuron"},{"key":"10.1093\/advances\/nmaa180_bib14","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1002\/ana.20899","article-title":"Mitochondrial biogenesis in the anticonvulsant mechanism of the ketogenic diet","volume":"60","author":"Bough","year":"2006","journal-title":"Ann Neurol"},{"key":"10.1093\/advances\/nmaa180_bib15","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/1743-7075-2-28","article-title":"A ketogenic diet reduces amyloid beta 40 and 42 in a mouse model of Alzheimer's disease","volume":"2","author":"Van Der Auwera","year":"2005","journal-title":"Nutr Metab (Lond)"},{"issue":"6","key":"10.1093\/advances\/nmaa180_bib16","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1096\/fj.04-3182fje","article-title":"Caloric restriction attenuates beta-amyloid neuropathology in a mouse model of Alzheimer's disease","volume":"19","author":"Wang","year":"2005","journal-title":"FASEB J"},{"key":"10.1093\/advances\/nmaa180_bib17","doi-asserted-by":"crossref","first-page":"5440","DOI":"10.1073\/pnas.97.10.5440","article-title":"D-b-Hydroxybutyrate protects neurons in models of Alzheimer's and Parkinson's disease","volume":"97","author":"Kashiwaya","year":"2000","journal-title":"Proc Natl Acad Sci"},{"key":"10.1093\/advances\/nmaa180_bib18","doi-asserted-by":"crossref","first-page":"4318","DOI":"10.1073\/pnas.94.9.4318","article-title":"Fatty acids and eicosanoids regulate gene expression through direct interactions with peroxisome proliferator-activated receptors \u03b1 and \u03b3","volume":"94","author":"Kliewer","year":"1997","journal-title":"Proc Natl Acad Sci"},{"key":"10.1093\/advances\/nmaa180_bib19","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1021\/bi9816094","article-title":"Ligand selectivity of the peroxisome proliferator-activated receptor \u03b1","volume":"38","author":"Lin","year":"1999","journal-title":"Biochemistry"},{"key":"10.1093\/advances\/nmaa180_bib20","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.plefa.2003.09.008","article-title":"The ketogenic diet; fatty acids, fatty acid-activated receptors and neurological disorders","volume":"70","author":"Cullingford","year":"2004","journal-title":"Prostaglandins, Leukotrienes Essent Fatty Acids"},{"key":"10.1093\/advances\/nmaa180_bib21","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1016\/j.neurobiolaging.2004.09.014","article-title":"Caloric restriction attenuates A\u03b2-deposition in Alzheimer transgenic models","volume":"26","author":"Patel","year":"2005","journal-title":"Neurobiol Aging"},{"issue":"6","key":"10.1093\/advances\/nmaa180_bib22","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0218112","article-title":"How do impairments in cognitive functions affect activities of daily living functions in older adults?","volume":"14","author":"Lee","year":"2019","journal-title":"PLoS One"},{"key":"10.1093\/advances\/nmaa180_bib23","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1046\/j.1471-4159.2002.00905.x","article-title":"Docosahexaenoic acid provides protection from impairment of learning ability in Alzheimer's disease model rats","volume":"81","author":"Hashimoto","year":"2002","journal-title":"J Neurochem"},{"key":"10.1093\/advances\/nmaa180_bib24","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1093\/jn\/135.3.549","article-title":"Chronic administration of docosahexaenoic acid ameliorates the impairment of spatial cognition learning ability in amyloid \u03b2 infused rats","volume":"135","author":"Hashimoto","year":"2005","journal-title":"J Nutr"},{"key":"10.1093\/advances\/nmaa180_bib25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fnins.2019.00005","article-title":"Ketogenic diet and epilepsy: what we know so far","volume":"13","author":"D\u2019Andrea Meira","year":"2019","journal-title":"Front Neurosci"},{"key":"10.1093\/advances\/nmaa180_bib26","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.yebeh.2015.10.021","article-title":"A prospective study of the modified Atkins diet for adults with idiopathic generalized epilepsy","volume":"53","author":"Kverneland","year":"2015","journal-title":"Epilepsy Behav"},{"key":"10.1093\/advances\/nmaa180_bib27","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/S1474-4422(08)70092-9","article-title":"The ketogenic diet for the treatment of childhood epilepsy: a randomised controlled trial","volume":"7","author":"Neal","year":"2008","journal-title":"Lancet Neurol"},{"key":"10.1093\/advances\/nmaa180_bib28","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1002\/epi4.12098","article-title":"Ketogenic diet for treatment of intractable epilepsy in adults: a meta-analysis of observational studies","volume":"3","author":"Liu","year":"2018","journal-title":"Epilepsia Open"},{"key":"10.1093\/advances\/nmaa180_bib29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/nu11051104","article-title":"Food and food products on the Italian market for ketogenic dietary treatment of neurological diseases","volume":"11","author":"Leone","year":"2019","journal-title":"Nutrients"},{"key":"10.1093\/advances\/nmaa180_bib30","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1177\/0883073807301926","article-title":"Kidney stones and the ketogenic diet: risk factors and prevention","volume":"22","author":"Sampath","year":"2007","journal-title":"J Child Neurol"},{"key":"10.1093\/advances\/nmaa180_bib31","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s004670000443","article-title":"Risk factors for urolithiasis in children on the ketogenic diet","volume":"15","author":"Furth","year":"2000","journal-title":"Pediatr Nephrol"},{"key":"10.1093\/advances\/nmaa180_bib32","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1093\/ajcn\/nqz145","article-title":"The impact of keto-adaptation on exercise performance and the role of metabolic-regulating cytokines","volume":"110","author":"Sherrier","year":"2019","journal-title":"Am J Clin Nutr"},{"key":"10.1093\/advances\/nmaa180_bib33","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1111\/ane.12137","article-title":"Modified Atkins diet vs classic ketogenic formula in intractable epilepsy","volume":"128","author":"El-Rashidy","year":"2013","journal-title":"Acta Neurol Scand"},{"key":"10.1093\/advances\/nmaa180_bib34","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.eplepsyres.2012.06.007","article-title":"Alternative diets to the classical ketogenic diet \u2013 can we be more liberal?","volume":"100","author":"Miranda","year":"2012","journal-title":"Epilepsy Res"},{"key":"10.1093\/advances\/nmaa180_bib35","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1000097","article-title":"Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement","volume":"6","author":"Moher","year":"2009","journal-title":"PLoS Med"},{"key":"10.1093\/advances\/nmaa180_bib36","doi-asserted-by":"crossref","first-page":"420","DOI":"10.5195\/jmla.2018.345","article-title":"The impact of PICO as a search strategy tool on literature search quality: a systematic review","volume":"106","author":"Eriksen","year":"2018","journal-title":"J Med Libr Assoc"},{"key":"10.1093\/advances\/nmaa180_bib37","author":"ICD Codes"},{"key":"10.1093\/advances\/nmaa180_bib38","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.d5928","article-title":"The Cochrane Collaboration\u2019s tool for assessing risk of bias in randomised trials","volume":"343","author":"Higgins","year":"2011","journal-title":"BMJ"},{"key":"10.1093\/advances\/nmaa180_bib39","article-title":"ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions","volume":"355","author":"Sterne","year":"2016","journal-title":"BMJ"},{"key":"10.1093\/advances\/nmaa180_bib40","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1136\/bmj.39489.470347.AD","article-title":"GRADE: an emerging consensus on rating quality of evidence and strength of recommendations","volume":"336","author":"Guyatt","year":"2008","journal-title":"BMJ"},{"key":"10.1093\/advances\/nmaa180_bib41","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1136\/bmj.39490.551019.BE","article-title":"GRADE: what is \u201cquality of evidence\u201d and why is it important to clinicians?","volume":"336","author":"Guyatt","year":"2008","journal-title":"BMJ"},{"key":"10.1093\/advances\/nmaa180_bib42","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1136\/bmj.39493.646875.AE","article-title":"GRADE: going from evidence to recommendations","volume":"336","author":"Guyatt","year":"2008","journal-title":"BMJ"},{"key":"10.1093\/advances\/nmaa180_bib43","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1136\/ebmed-2017-110668","article-title":"Rating the certainty in evidence in the absence of a single estimate of effect","volume":"22","author":"Murad","year":"2017","journal-title":"Evid Based Med"},{"key":"10.1093\/advances\/nmaa180_bib44","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.exger.2018.07.009","article-title":"Changes in regional cerebral blood flow associated with a 45 day course of the ketogenic agent, caprylidene, in patients with mild to moderate Alzheimer's disease: results of a randomized, double-blinded, pilot study","volume":"111","author":"Torosyan","year":"2018","journal-title":"Exp Gerontol"},{"key":"10.1093\/advances\/nmaa180_bib45","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fmicb.2017.01141","article-title":"Reduced mass and diversity of the colonic microbiome in patients with multiple sclerosis and their improvement with ketogenic diet","volume":"8","author":"Swidsinski","year":"2017","journal-title":"Front Microbiol"},{"key":"10.1093\/advances\/nmaa180_bib46","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1743-7075-6-31","article-title":"Study of the ketogenic agent AC-1202 in mild to moderate Alzheimer's disease: a randomized, double-blind, placebo-controlled, multicenter trial","volume":"6","author":"Henderson","year":"2009","journal-title":"Nutr Metab"},{"key":"10.1093\/advances\/nmaa180_bib47","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1186\/1471-2350-12-137","article-title":"Pharmacogenetic analysis of the effects of polymorphisms in APOE, IDE and IL1B on a ketone body based therapeutic on cognition in mild to moderate Alzheimer's disease; a randomized, double-blind, placebo-controlled study","volume":"12","author":"Henderson","year":"2011","journal-title":"BMC Med Genet"},{"key":"10.1093\/advances\/nmaa180_bib48","doi-asserted-by":"crossref","first-page":"547","DOI":"10.3233\/JAD-191302","article-title":"A placebo-controlled, parallel-group, randomized clinical trial of AC-1204 in mild-to-moderate Alzheimer's disease","volume":"75","author":"Henderson","year":"2020","journal-title":"J Alzheimer's Dis"},{"key":"10.1093\/advances\/nmaa180_bib49","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.jalz.2018.12.017","article-title":"A ketogenic drink improves brain energy and some measures of cognition in mild cognitive impairment","volume":"15","author":"Fortier","year":"2019","journal-title":"Alzheimer's Dement"},{"key":"10.1093\/advances\/nmaa180_bib50","doi-asserted-by":"crossref","first-page":"2136","DOI":"10.1016\/j.celrep.2016.05.009","article-title":"A diet mimicking fasting promotes regeneration and reduces autoimmunity and multiple sclerosis symptoms","volume":"15","author":"Choi","year":"2016","journal-title":"Cell Rep"},{"key":"10.1093\/advances\/nmaa180_bib51","doi-asserted-by":"crossref","first-page":"969","DOI":"10.3233\/JAD-180995","article-title":"Preliminary report on the feasibility and efficacy of the modified Atkins diet for treatment of mild cognitive impairment and early Alzheimer's disease","volume":"68","author":"Brandt","year":"2019","journal-title":"J Alzheimer's Dis"},{"key":"10.1093\/advances\/nmaa180_bib52","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.ebiom.2018.08.057","article-title":"Ketogenic diets attenuate cyclooxygenase and lipoxygenase gene expression in multiple sclerosis","volume":"36","author":"Bock","year":"2018","journal-title":"EBioMedicine"},{"issue":"7","key":"10.1093\/advances\/nmaa180_bib53","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.1016\/j.clnu.2019.10.017","article-title":"Medium-chain triglycerides improved cognition and lipid metabolomics in mild to moderate Alzheimer\u2019s disease patients with APOE4\u2212\/\u2212: a double-blind, randomized, placebo-controlled crossover trial","volume":"39","author":"Xu","year":"2020","journal-title":"Clin Nutr"},{"key":"10.1093\/advances\/nmaa180_bib54","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1159\/000197108","article-title":"Short-term effects of prolonged fasting on multiple sclerosis","volume":"61","author":"Saadatnia","year":"2009","journal-title":"Eur Neurol"},{"key":"10.1093\/advances\/nmaa180_bib55","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.bbacli.2015.01.001","article-title":"Pilot feasibility and safety study examining the effect of medium chain triglyceride supplementation in subjects with mild cognitive impairment: a randomized controlled trial","volume":"3","author":"Rebello","year":"2015","journal-title":"BBA Clin"},{"key":"10.1093\/advances\/nmaa180_bib56","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1002\/mds.27390","article-title":"Low-fat versus ketogenic diet in Parkinson's disease: a pilot randomized controlled trial","volume":"33","author":"Phillips","year":"2018","journal-title":"Mov Disord"},{"key":"10.1093\/advances\/nmaa180_bib57","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.neurobiolaging.2019.09.015","article-title":"Modified ketogenic diet is associated with improved cerebrospinal fluid biomarker profile, cerebral perfusion, and cerebral ketone body uptake in older adults at risk for Alzheimer's disease: a pilot study","volume":"86","author":"Neth","year":"2020","journal-title":"Neurobiol Aging"},{"key":"10.1093\/advances\/nmaa180_bib58","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.ebiom.2019.08.032","article-title":"Modified Mediterranean-ketogenic diet modulates gut microbiome and short-chain fatty acids in association with Alzheimer's disease markers in subjects with mild cognitive impairment","volume":"47","author":"Nagpal","year":"2019","journal-title":"EBioMedicine"},{"key":"10.1093\/advances\/nmaa180_bib59","first-page":"1","article-title":"A modified MCT-based ketogenic diet increases plasma \u03b2-hydroxybutyrate but has less effect on fatigue and quality of life in people with multiple sclerosis compared to a modified paleolithic diet: a waitlist-controlled, randomized pilot study","volume":"0","author":"Lee","year":"2020","journal-title":"J Am Coll Nutr"},{"key":"10.1093\/advances\/nmaa180_bib60","first-page":"41","article-title":"Nutritional ketosis for mild cognitive impairment in Parkinson's disease: a controlled pilot trial","volume":"1","author":"Krikorian","year":"2019","journal-title":"Clin Park Relat Disord"},{"key":"10.1093\/advances\/nmaa180_bib61","doi-asserted-by":"crossref","DOI":"10.1016\/j.neurobiolaging.2010.10.006","article-title":"Dietary ketosis enhances memory in mild cognitive impairment","volume":"33","author":"Krikorian","year":"2012","journal-title":"Neurobiol Aging"},{"key":"10.1093\/advances\/nmaa180_bib62","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1002\/gps.2319","article-title":"The ADAS-cog and clinically meaningful change in the VISTA clinical trial of galantamine for Alzheimer's disease","volume":"25","author":"Rockwood","year":"2010","journal-title":"Int J Geriat Psychiatry"},{"key":"10.1093\/advances\/nmaa180_bib63","doi-asserted-by":"crossref","first-page":"423","DOI":"10.3233\/JAD-170991","article-title":"The Alzheimer's Disease Assessment Scale-Cognitive Subscale (ADAS-Cog): modifications and responsiveness in pre-dementia populations. A narrative review","volume":"63","author":"Kueper","year":"2018","journal-title":"JAD"},{"key":"10.1093\/advances\/nmaa180_bib64","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1177\/088307380001501203","article-title":"The ketogenic diet: seizure control correlates better with serum \u03b2-hydroxybutyrate than with urine ketones","volume":"15","author":"Gilbert","year":"2000","journal-title":"J Child Neurol"},{"key":"10.1093\/advances\/nmaa180_bib65","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2377-7-26","article-title":"The clinical meaningfulness of ADAS-Cog changes in Alzheimer's disease patients treated with donepezil in an open-label trial","volume":"7","author":"Rockwood","year":"2007","journal-title":"BMC Neurol"},{"key":"10.1093\/advances\/nmaa180_bib66","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1136\/jnnp-2011-300881","article-title":"What is the clinically relevant change on the ADAS-Cog?","volume":"83","author":"Schrag","year":"2012","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1093\/advances\/nmaa180_bib67","doi-asserted-by":"crossref","DOI":"10.3945\/cdn.117.000851","article-title":"Emulsification increases the acute ketogenic effect and bioavailability of medium-chain triglycerides in humans","volume":"1","author":"Courchesne-Loyer","year":"2017","journal-title":"Curr Dev Nutr"},{"key":"10.1093\/advances\/nmaa180_bib68","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1007\/s12170-011-0189-x","article-title":"Cardiovascular disease risk factors and cognition in the elderly","volume":"5","author":"Leritz","year":"2011","journal-title":"Curr Cardiovasc Risk Rep"},{"key":"10.1093\/advances\/nmaa180_bib69","doi-asserted-by":"crossref","first-page":"S16","DOI":"10.1016\/j.jalz.2007.01.001","article-title":"Cardiovascular risk factors and cognitive function","volume":"3","author":"Grodstein","year":"2007","journal-title":"Alzheimer\u2019s & Dementia"},{"key":"10.1093\/advances\/nmaa180_bib70","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1743-7075-2-34","article-title":"A low-carbohydrate, ketogenic diet to treat type 2 diabetes","volume":"2","author":"Yancy","year":"2005","journal-title":"Nutr Metab (Lond)"},{"key":"10.1093\/advances\/nmaa180_bib71","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1016\/j.nut.2012.01.016","article-title":"Effect of low-calorie versus low-carbohydrate ketogenic diet in type 2 diabetes","volume":"28","author":"Hussain","year":"2012","journal-title":"Nutrition"},{"key":"10.1093\/advances\/nmaa180_bib72","doi-asserted-by":"crossref","first-page":"S44","DOI":"10.1093\/aje\/kws264","article-title":"Effects of low-carbohydrate diets versus low-fat diets on metabolic risk factors: a meta-analysis of randomized controlled clinical trials","volume":"176","author":"Hu","year":"2012","journal-title":"Am J Epidemiol"},{"key":"10.1093\/advances\/nmaa180_bib73","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/s11010-007-9448-z","article-title":"Beneficial effects of ketogenic diet in obese diabetic subjects","volume":"302","author":"Dashti","year":"2007","journal-title":"Mol Cell Biochem"},{"key":"10.1093\/advances\/nmaa180_bib74","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/S0197-4580(03)00087-3","article-title":"Effects of \u03b2-hydroxybutyrate on cognition in memory-impaired adults","volume":"25","author":"Reger","year":"2004","journal-title":"Neurobiol Aging"},{"key":"10.1093\/advances\/nmaa180_bib75","doi-asserted-by":"crossref","first-page":"4452","DOI":"10.3390\/nu6104452","article-title":"Fatty acid metabolism in carriers of apolipoprotein e epsilon 4 allele: is it contributing to higher risk of cognitive decline and coronary heart disease?","volume":"6","author":"Chouinard-Watkins","year":"2014","journal-title":"Nutrients"},{"key":"10.1093\/advances\/nmaa180_bib76","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1017\/S000711450938215X","article-title":"Plasma n\u20133 fatty acid response to an n\u20133 fatty acid supplement is modulated by apoE 4 but not by the common PPAR-L162V polymorphism in men","volume":"102","author":"Plourde","year":"2009","journal-title":"Br J Nutr"},{"key":"10.1093\/advances\/nmaa180_bib77","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.neuropharm.2018.01.044","article-title":"Brain insulin signalling, glucose metabolism and females' reproductive aging: a dangerous triad in Alzheimer's disease","volume":"136","author":"Duarte","year":"2018","journal-title":"Neuropharmacology"},{"key":"10.1093\/advances\/nmaa180_bib78","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fnagi.2019.00315","article-title":"Sex and gender driven modifiers of Alzheimer's: the role for estrogenic control across age, race, medical, and lifestyle risks","volume":"11","author":"Rahman","year":"2019","journal-title":"Front Aging Neurosci"},{"issue":"4","key":"10.1093\/advances\/nmaa180_bib79","doi-asserted-by":"crossref","first-page":"225","DOI":"10.14283\/jpad.2018.34","article-title":"Female sex and Alzheimer's risk: the menopause connection","volume":"5","author":"Scheyer","year":"2018","journal-title":"J Prev Alzheimer's Dis"},{"key":"10.1093\/advances\/nmaa180_bib80","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0207885","article-title":"Increased Alzheimer's risk during the menopause transition: a 3-year longitudinal brain imaging study","volume":"13","author":"Mosconi","year":"2018","journal-title":"PLoS One"},{"key":"10.1093\/advances\/nmaa180_bib81","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1016\/j.addr.2008.06.003","article-title":"Estrogen regulation of glucose metabolism and mitochondrial function: therapeutic implications for prevention of Alzheimer's disease","volume":"60","author":"Brinton","year":"2008","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1093\/advances\/nmaa180_bib82","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1007\/s40263-017-0444-x","article-title":"Health-related quality of life in patients with multiple sclerosis: impact of disease-modifying drugs","volume":"31","author":"Jongen","year":"2017","journal-title":"CNS Drugs"},{"issue":"8","key":"10.1093\/advances\/nmaa180_bib83","article-title":"Dietary therapy in secondary progressive multiple sclerosis: a case report","volume":"11","author":"Nathan","year":"2019","journal-title":"Cureus"},{"issue":"4","key":"10.1093\/advances\/nmaa180_bib84","doi-asserted-by":"crossref","first-page":"e565","DOI":"10.1212\/NXI.0000000000000565","article-title":"Pilot study of a ketogenic diet in relapsing-remitting MS","volume":"6","author":"Brenton","year":"2019","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"10.1093\/advances\/nmaa180_bib85","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2015\/681289","article-title":"The therapeutic potential of the ketogenic diet in treating progressive multiple sclerosis","volume":"2015","author":"Storoni","year":"2015","journal-title":"Mult Scler Int"},{"key":"10.1093\/advances\/nmaa180_bib86","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1002\/mds.23961","article-title":"Nonmotor versus motor symptoms: how much do they matter to health status in Parkinson's disease?","volume":"27","author":"Hinnell","year":"2012","journal-title":"Mov Disord"},{"key":"10.1093\/advances\/nmaa180_bib87","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1002\/mds.22049","article-title":"Levodopa unresponsive symptoms in Parkinson disease","volume":"23","author":"Sethi","year":"2008","journal-title":"Mov Disord"},{"key":"10.1093\/advances\/nmaa180_bib88","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.nbd.2010.05.030","article-title":"Acute oxidative stress and systemic Nrf2 activation by the ketogenic diet","volume":"40","author":"Milder","year":"2010","journal-title":"Neurobiol Dis"},{"key":"10.1093\/advances\/nmaa180_bib89","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2018\/2630565","article-title":"The effect of medium chain triglycerides on time to nutritional ketosis and symptoms of keto-induction in healthy adults: a randomised controlled clinical trial","volume":"2018","author":"Harvey","year":"2018","journal-title":"J Nutr Metab"},{"key":"10.1093\/advances\/nmaa180_bib90","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.1212\/WNL.0000000000001004","article-title":"Dietary treatment in adults with refractory epilepsy: a review","volume":"83","author":"Klein","year":"2014","journal-title":"Neurology"},{"key":"10.1093\/advances\/nmaa180_bib91","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1471-2288-10-17","article-title":"Recruiting older people to a randomised controlled dietary intervention trial \u2013 how hard can it be?","volume":"10","author":"Forster","year":"2010","journal-title":"BMC Med Res Methodol"},{"key":"10.1093\/advances\/nmaa180_bib92","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1745-6215-13-111","article-title":"Long-term dietary intervention trials: critical issues and challenges","volume":"13","author":"Crichton","year":"2012","journal-title":"Trials"},{"key":"10.1093\/advances\/nmaa180_bib93","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1111\/j.1467-789X.2009.00567.x","article-title":"Attrition from randomized controlled trials of pharmacological weight loss agents: a systematic review and analysis: obesity management","volume":"10","author":"Fabricatore","year":"2009","journal-title":"Obes Rev"},{"key":"10.1093\/advances\/nmaa180_bib94","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1177\/1559827613488867","article-title":"Long-term adherence to health behavior change access","volume":"7","author":"Middleton","year":"2013","journal-title":"Am J Lifestyle Med"},{"key":"10.1093\/advances\/nmaa180_bib95","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.trci.2017.11.002","article-title":"Feasibility and efficacy data from a ketogenic diet intervention in Alzheimer' s disease","volume":"4","author":"Taylor","year":"2018","journal-title":"Alzheimer's Dement Transl Res Clin Interv"},{"key":"10.1093\/advances\/nmaa180_bib96","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13063-019-3996-x","article-title":"Evaluation of the safety and tolerability of a nutritional Formulation in patients with ANgelman Syndrome (FANS): study protocol for a randomized controlled trial","volume":"21","author":"Herber","year":"2020","journal-title":"Trials"},{"key":"10.1093\/advances\/nmaa180_bib97","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1900\/RDS.2016.13.217","article-title":"Blood ketones: measurement, interpretation, limitations, and utility in the management of diabetic ketoacidosis","volume":"13","author":"Dhatariya","year":"2016","journal-title":"Rev Diabet Stud"},{"key":"10.1093\/advances\/nmaa180_bib98","doi-asserted-by":"crossref","first-page":"852","DOI":"10.2337\/dc10-1844","article-title":"Diagnostic accuracy of point-of-care testing for diabetic ketoacidosis at emergency-department triage: \u03b2-hydroxybutyrate versus the urine dipstick","volume":"34","author":"Arora","year":"2011","journal-title":"Diabetes Care"},{"key":"10.1093\/advances\/nmaa180_bib99","doi-asserted-by":"crossref","DOI":"10.7717\/peerj.4488","article-title":"The use of nutritional supplements to induce ketosis and reduce symptoms associated with keto-induction: a narrative review","volume":"6","author":"Harvey","year":"2018","journal-title":"PeerJ"},{"key":"10.1093\/advances\/nmaa180_bib100","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fphys.2017.00848","article-title":"On the metabolism of exogenous ketones in humans","volume":"8","author":"Stubbs","year":"2017","journal-title":"Front Physiol"},{"key":"10.1093\/advances\/nmaa180_bib101","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s12986-016-0069-y","article-title":"Effects of exogenous ketone supplementation on blood ketone, glucose, triglyceride, and lipoprotein levels in Sprague-Dawley rats","volume":"13","author":"Kesl","year":"2016","journal-title":"Nutr Metab (Lond)"},{"key":"10.1093\/advances\/nmaa180_bib102","doi-asserted-by":"crossref","DOI":"10.14814\/phy2.13961","article-title":"Delaying latency to hyperbaric oxygen-induced CNS oxygen toxicity seizures by combinations of exogenous ketone supplements","volume":"7","author":"Ari","year":"2019","journal-title":"Physiol Rep"},{"key":"10.1093\/advances\/nmaa180_bib103","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fnins.2019.01041","article-title":"Ketone administration for seizure disorders: history and rationale for ketone esters and metabolic alternatives","volume":"13","author":"Poff","year":"2019","journal-title":"Front Neurosci"},{"key":"10.1093\/advances\/nmaa180_bib104","unstructured":"D'Agostino D, Arnold P, Kesl S. Compositions and Methods for Producing Elevated and Sustained Ketosis. International Patent WO2014153416A1, 2015."},{"key":"10.1093\/advances\/nmaa180_bib105","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fnut.2020.00003","article-title":"Medium chain triglycerides modulate the ketogenic effect of a metabolic switch","volume":"7","author":"Vandenberghe","year":"2020","journal-title":"Front Nutr"},{"key":"10.1093\/advances\/nmaa180_bib106","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fnut.2019.00046","article-title":"Plasma ketone and medium chain fatty acid response in humans consuming different medium chain triglycerides during a metabolic study day","volume":"6","author":"St-Pierre","year":"2019","journal-title":"Front Nutr"},{"key":"10.1093\/advances\/nmaa180_bib107","doi-asserted-by":"crossref","DOI":"10.3945\/cdn.116.000257","article-title":"Tricaprylin alone increases plasma ketone response more than coconut oil or other medium-chain triglycerides: an acute crossover study in healthy adults","volume":"1","author":"Vandenberghe","year":"2017","journal-title":"Curr Dev Nutr"},{"key":"10.1093\/advances\/nmaa180_bib108","doi-asserted-by":"crossref","first-page":"657","DOI":"10.3389\/fphys.2019.00657","article-title":"Differential metabolism of medium-chain fatty acids in differentiated human-induced pluripotent stem cell-derived astrocytes","volume":"10","author":"Sonnay","year":"2019","journal-title":"Front Physiol"},{"key":"10.1093\/advances\/nmaa180_bib109","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S0899-9007(96)00409-1","article-title":"Potential of ketone body esters for parenteral and oral nutrition","volume":"13","author":"Brunengraber","year":"1997","journal-title":"Nutrition"},{"key":"10.1093\/advances\/nmaa180_bib110","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/s41430-018-0327-3","article-title":"Effectiveness of interventions aimed at improving dietary behaviours among people at higher risk of or with chronic non-communicable diseases: an overview of systematic reviews","volume":"73","author":"Browne","year":"2019","journal-title":"Eur J Clin Nutr"},{"key":"10.1093\/advances\/nmaa180_bib111","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/s13643-016-0259-8","article-title":"Evaluation of the Cochrane tool for assessing risk of bias in randomized clinical trials: overview of published comments and analysis of user practice in Cochrane and non-Cochrane reviews","volume":"5","author":"J\u00f8rgensen","year":"2016","journal-title":"Syst Rev"}],"container-title":["Advances in Nutrition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S216183132200148X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S216183132200148X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/academic.oup.com\/advances\/article-pdf\/12\/4\/1571\/39397964\/nmaa180.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/advances\/article-pdf\/12\/4\/1571\/39397964\/nmaa180.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T01:00:33Z","timestamp":1761872433000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S216183132200148X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7]]},"references-count":111,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,7]]}},"alternative-id":["S216183132200148X"],"URL":"https:\/\/doi.org\/10.1093\/advances\/nmaa180","relation":{},"ISSN":["2161-8313"],"issn-type":[{"value":"2161-8313","type":"print"}],"subject":[],"published":{"date-parts":[[2021,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Efficacy of Ketogenic Therapies in the Clinical Management of People with Neurodegenerative Disease: A Systematic Review","name":"articletitle","label":"Article Title"},{"value":"Advances in Nutrition","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1093\/advances\/nmaa180","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Author(s). Published by ELSEVIERCOMPANY on behalf of American Society for Nutrition.","name":"copyright","label":"Copyright"}]}}